Chapter 80: Drugs for Asthma and Chronic Obstructive Pulmonary Disease

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

In 2020,

over 4 ,000 people died from asthma.

And here is the truly shocking part.

According to the Asthma and Allergy Foundation,

most of those deaths were entirely preventable.

Yeah, it is a staggering statistic.

And you know, it really reframes how we have to look at these medications.

I mean, it's not just about memorizing drug classes.

Right, absolutely.

Welcome to the deep dive.

If you are listening to this right now, consider this your plain language cause and effect masterclass on the pharmacology of asthma and COPD.

Exactly.

We are taking all that dense material from the standard nursing pharmacology curriculum and translating it for you.

Because when you are at the bedside and a patient is struggling to breathe, you aren't just handing them an inhaler.

You're making a split second decision based on, well, a deep understanding of what is physically happening inside their lungs.

Right.

And you have to understand the why behind safe medication decisions, because the difference between a short acting and long acting bronchodilator isn't just like a test question.

If used incorrectly, it can literally be fatal.

So let's start before the drugs.

Let's look at the actual plumbing of the lungs.

Because to fix the problem, we have to know exactly what is broken.

Makes sense.

So if we picture the airways like a complex ventilation system,

the main pipes branch off into smaller and smaller tubes, right?

Eventually ending in millions of tiny elastic air sacs called alveoli.

What is actually happening to that system in asthma versus COPD?

Well, there are completely different mechanical failures.

So let's look at asthma first.

Asthma is primarily an immune mediated inflammatory cascade.

Okay.

Immune mediated.

Yeah.

Think of the airways as being lined with microscopic landmines called mast cells.

In a susceptible person, when they inhale an allergen, that allergen binds to specific IgE antibodies sitting right on top of those mast cells.

And when that happens, the landmine explodes.

Precisely.

The mast cell bursts, which is a process called degranulation, releasing this massive payload of chemical mediators into the airway.

We are talking about histamine, leukotrienes, interleukins, and prostaglandins.

Wow.

Okay.

What do all those chemicals actually do to the airway, though?

They cause an immediate two -part crisis.

First, intense bronchoconstriction.

The smooth muscle wrapping around those ventilation pipes just violently squeezes tight.

Okay.

So the pipes are squeezing shut.

Right.

And second, those chemicals act as a distress signal, calling in an invasion of inflammatory cells like eosinophils and leukocytes.

This causes the inner lining of the airway to swell up with edema and secrete thick, sticky mucus.

Oh, wow.

So the pipes are being crushed from the outside by muscle spasms and simultaneously clogged from the inside by swelling and mucus.

Yes.

And because of this constant low -level inflammation, the airways are left in a permanent state of bronchial hyperreactivity.

Meaning they are just always on edge.

Exactly.

Even when the patient feels fine, their airways are so sensitive that a minor trigger like a blast of cold air or even just going for a jog can trigger a massive spasm.

Okay.

I can visualize asthma.

Now contrast that with COPD because the underlying mechanics there are completely different, right?

Very different.

So COPD, which stands for chronic obstructive pulmonary disease, is largely irreversible.

In the vast majority of cases, it is caused by cigarette smoke.

Though there is a small genetic component sometimes, right?

Yeah.

A small percentage is caused by a genetic condition called alpha -1 antitrypsin deficiency.

But clinically, COPD is actually a combination of two distinct destructive processes,

chronic bronchitis and emphysema.

Chronic bronchitis just sounds like an overproduction of mucus.

Is that just from the constant irritation of the smoke?

Exactly.

The continuous irritation causes constant bronchiolidema.

To protect itself, the airway's mucus -secreting glands actually hypertrophy.

They grow larger.

Right.

They grow larger and just pump out excessive amounts of mucus, leading to that chronic hacking cough you see in these patients.

And then there's emphysema.

What is the actual mechanism breaking the lungs down there?

Well, this is where it gets really destructive.

The lung naturally produces protease enzymes.

Think of them as like chemical scissors.

Usually we have inhibitors that keep those scissors in check.

But the constant inflammation from smoke actually paralyzes those protective inhibitors.

So the chemical scissors just run wild.

Yes, exactly.

The protease enzymes literally eat away at the lung's elastin.

They destroy the walls of those tiny alveolar air sacs.

Oh, it's terrible.

Yeah.

Those tight elastic little balloons lose their stretch and merge into big, floppy, useless spaces that just trap air.

I mean, that is a critical distinction to lock in for you as a nursing student.

Asthma is an allergic, inflammatory hyperreaction where the airway squeezed shut.

But COPD is a chronic, progressive destruction of the lung tissue itself.

And that distinction dictates every pharmacological choice you were going to make at the bedside.

Which brings us to the drugs.

We understand the physical roadblocks now.

But getting the medicine past the blockade is a challenge in itself, isn't it?

It really is.

Like if swallowing a pill means sending the drug through the stomach, the liver, and the bloodstream before it ever reaches the lungs,

why is the inhalation route so heavily emphasized here?

It's kind of like a precision strike instead of carpet bombing, right?

That's a great way to put it.

Inhalation offers three massive advantages.

First,

therapeutic effects are dramatically enhanced because you're delivering the drug directly to the site of action.

Right.

Second,

systemic side effects are minimized because the drug isn't just flooding the rest of the body.

And third, relief is rapid.

During an acute asthma attack, seconds really matter.

But getting aerosolized medicine into the lungs isn't just breathing in.

Let's talk about the delivery devices.

Starting with the classic meter dose inhalers, or MDIs.

These are the small pressurized canisters everyone is familiar with.

Right.

So MDIs require strict hand -breath coordination.

You have to begin inhaling right before you press the canister.

But most patients really struggle with that coordination.

What happens if they get it wrong?

Well, even if they get it right, the physics of an MDI are tough.

The medication shoots out so fast, without a spacer, only 9 % of the medication actually reaches the lungs.

Wait, really?

Only 9 %?

Yeah.

A staggering 81 % just slams into the back of the mouth and throat where it gets swallowed.

So you are losing over 80 % of the active drug to the digestive tract.

How does a spacer fix that?

A spacer is essentially a plastic tube that attaches to the mouthpiece.

It does two key things.

It slows down the velocity of the mist, and it separates the large medication particles from the fine ones.

Okay.

So when a patient uses a spacer, lung delivery jumps from 9 % to 21%.

Oh, wow.

That's a huge difference.

It is.

It dramatically reduces the amount of swallowed drug and prevents local side effects in the mouth.

That makes total sense.

Now, besides MDIs, we also have respimates, which deliver a very fine mist without propellants, getting even more drug to the lungs.

And then there are DPIs, or dry powder inhalers.

DPIs are brilliant because they are breath activated.

There is no propellant, so the patient doesn't need that tricky hand -breath coordination.

So they just inhale?

Yeah.

The sheer force of their own deep inhale pulls the dry powder out of the device, delivering about 20 % to the lungs.

And finally, nebulizers.

These are machines that take a liquid medication and convert it into a fine mist over several minutes, right?

Correct.

The patient just sits there breathing normally through a mask or mouthpiece.

It takes much longer.

But it's vital for patients in severe respiratory distress who physically cannot coordinate an inhaler.

Exactly.

So now that we know how we are delivering the drugs, we need to look at what we are delivering.

Following the exact order of the chapter, let's start with the foundation of long -term control.

The anti -inflammatory agents.

Right.

The anti -inflammatories.

If we think of asthma as a smoldering fire inside those ventilation pipes, anti -inflammatories are basically the water keeping the embers cool.

Let's unpack the absolute heavy hitters first.

Glucocorticoids.

Glucocorticoids are the first -line therapy for asthma.

Their mechanism of action is profound.

They work at the cellular level to just turn off the inflammatory response.

How so?

They decrease the synthesis and release of those chemical mediators we talked about earlier.

Leukotrienes, histamine, prostaglandins.

They also stop the inflammatory cells from infiltrating the airway.

So they drastically reduce the swelling in the mucus.

Yes.

And they have a brilliant bonus effect.

They actually increase the number and responsiveness of beta -2 receptors in the lungs.

Meaning they actually make the bronchodilator rescue drugs work better when the patient needs them.

That is incredible.

It really is a powerful synergy.

Now, we mostly use inhaled glucocorticoids, like buclomethazone and fluticasone.

The major nursing implication here is that these must be taken daily on a fixed schedule.

They are not for PRN, as needed rescue rate.

Right.

They are preventing the fire, not putting it out once it is blazing.

And because they are inhaled, the adverse effects are mostly local to the throat.

Like what?

Specifically, oropharyngeal candidiasis, which is better known as oral thrush, and dysphonia, which is hoarseness.

Because you are basically suppressing the local immune system in the mouth, allowing yeast to overgrow.

Exactly.

So the mandatory patient teaching point here is to have the patient aggressively rinse their mouth with water and spit it out after every single use.

Simple, but vital.

Now, what about oral glucocorticoids, like prednisone?

We only use those briefly for severe asthma or COPD exacerbations, right?

Yes, and we use them as briefly as possible because the systemic toxicities are severe.

And this brings up a critical safety alert regarding prolonged systemic use,

adrenal insufficiency.

Okay, let's break that down.

Why does taking a steroid pill cause adrenal insufficiency?

Well, your adrenal glands naturally produce low levels of glucocorticoids all the time to keep your body functioning.

If you give a patient a high dose of synthetic oral glucocorticoids for a prolonged period, the brain senses all those steroids in the blood and tells the adrenal glands to stop working.

Basically telling them they aren't needed right now.

Yeah, the adrenal glands basically go on vacation.

So if you just suddenly stop prescribing the medication.

The patient crashes, they go into acute withdrawal because their adrenal glands haven't woken up yet, and they now have zero steroids in their system.

And it gets worse during physical trauma, right?

Yeah.

Because normally during severe physical stress like a surgery or a car crash,

your adrenal glands pump out a massive spike of glucocorticoids to maintain blood pressure and blood sugar.

Exactly.

If the patient's adrenal glands are suppressed from long -term steroid use and they experience major physical stress, they cannot mount that natural stress response.

Oh, wow.

Yeah.

If you don't proactively give them supplemental systemic glucocorticoids in the hospital, they can suffer cardiovascular collapse and die.

That is terrifying.

No.

So tapers are non -negotiable.

You have to slowly wean them off oral steroids to give the adrenal glands time to wake up.

Non -negotiable, yes.

Okay.

Moving down the line of anti -inflammatories, we have the leukotrine modifiers.

These are second -line oral medications.

Xylotin blocks leukotrine synthesis, while Xafrileucast and Montelucast block the leukotrine receptors.

Right.

To understand these, remember that leukotrienes are one of those chemical mediators released by the bursting mast cells.

They specifically promote smooth muscle constriction, blood vessel permeability, and inflammatory cell recruitment.

So by blocking them, you reduce bronchoconstriction and edema.

What are the risks with these?

Well, all three carry a rare but serious risk of neuropsychiatric effects.

We are talking about depression, anxiety, and even suicidal thoughts.

Patients really need to be monitored for mood changes.

For to know.

But physiologically, they differ.

Xyloton and Xafrileucast can cause severe liver injury.

And don't they interact dangerously with other drugs?

They do.

They inhibit liver enzymes, which means they can drastically drive up the blood levels of drugs, like theophylline and warfarin, leading to toxicity.

But Montelucast, I think the brand name is Singulair,

is generally considered much safer.

Right.

It is the preferred choice.

Montelucast does not carry the liver injury risk, and it does not have those dangerous metabolic drug interactions, though the neuropsychiatric warning still applies.

Okay, next we have a mast cell stabilizer called Cromalin.

This is an inhaled drug.

Cromalin is incredibly safe.

It works exactly as the name implies.

It coats the mast cells and stabilizes their outer membrane so they physically cannot burst and release histamine.

But it is purely prophylactic, right?

It does nothing to relax airway muscles that are already in spasm.

Exactly.

It's preventative.

So it's especially great for something like exercise -induced bronchospasm.

The patient just takes it 10 to 15 minutes before they go for a run to stabilize the cells ahead of time.

Precisely.

Now, rounding out the anti -inflammatories, we are entering the era of biologic therapies, the monoclonal antibodies.

These are sub -Q or IV injections strictly reserved for severe refractory asthma.

Like omelazumab, which specifically binds up the IgE antibodies so they can attach to the mast cells in the first place, or interleukin -5 antagonists like rizazumab.

Yes, but you have to be hypervigilant with rizazumab.

It carries a black box warning for anaphylaxis.

Patients must be closely observed after administration.

Wow, okay.

There's one more anti -inflammatory to mention here, a PDE4 inhibitor called roflumelast.

But it's crucial to note this is approved only for severe COPD to reduce exacerbations.

It's not for asthma.

Correct.

Roflumelast works by inhibiting an enzyme, which raises levels of a molecule called CAMMP in the lung cells.

What does that do?

Think of CAMMPP as a cellular off -switch for inflammation.

By keeping CAMMP levels high, it significantly cuts down on the chronic cough and excessive mucus production that really plagues COPD patients.

All right, so anti -inflammatories are the long -term fire prevention.

But what if the patient is acutely suffocating right now?

That brings us to our second major pharmacological class, bronchodilators.

Right.

If anti -inflammatories fix the underlying swelling,

bronchodilators are basically the crowbar that pries the smooth muscle open.

Let's walk through the beta -2 adrenergic agonists.

The mechanism of action here is pretty straightforward.

These drugs bind to and activate beta -2 receptors located in the smooth muscle of the lung.

And then?

When activated, those receptors signal the spasming muscle to finally relax and let go, promoting immediate bronchodilation.

So instead of a crowbar crying the airway open, it's actually more like turning the key to shut off a blaring car alarm.

The muscle just releases.

I like that analogy.

Now we have to strictly separate the short -acting from the long -acting versions.

This is literally life and death.

Absolutely.

The short -acting beta -2 agonists, or sabas like albuterol, are the ultimate PRN rescue inhaler.

They work almost instantly.

Wait, hold on.

If beta -2 receptors are primarily in the lungs,

why is there a major safety alert about adverse heart effects with albuterol?

Aren't the heart receptors beta -1?

That is a great catch.

You are right.

The heart is primarily beta -1, and lungs are beta -2.

But albuterol is only relatively selective.

So if a patient takes too much of it?

It loses that selectivity and spills over to activate the beta -1 receptors in the heart.

So excessive dosing causes cardiac side effects.

Exactly.

Overuse can cause dangerous tachydysthythmias, angina, seizures, and even cardiac arrests.

The strict clinical rule is this.

If a patient needs their sabah rescue inhaler more than twice a week to control symptoms, their baseline anti -inflammatory therapy is failing.

You don't just keep giving them more albuterol, you have to step up their glucocorticoid dose.

Okay, then we have the long -acting beta -2 agonists, or LABAs, like salmeterol.

These are for long -term control, taken on a fixed schedule.

But this is arguably the most critical black box warning in respiratory pharmacology.

In asthma,

LABAs must never be used as monotherapy.

Never.

If you give a LABA by itself to an asthmatic, it acts like a deadly band -aid.

It keeps the airway muscle relaxed and propped open so the patient feels fine.

But it does absolutely nothing to stop the underlying inflammatory fire.

Right.

The edema and mucus build up unchecked until the airway completely swells shut from the inside, leading to asthma -related death.

In asthma, a LABA must always, always be combined with an inhaled glucocorticoid.

Okay, now, in COPD, because the primary driver isn't that allergic inflammatory cascade,

LABAs can be used alone.

Moving on, let's talk about an older oral bronchodilator that requires intense monitoring.

Baffle of xanthines, specifically theophylline.

Theophylline is rarely used today because it has a highly dangerous, incredibly narrow therapeutic index.

The target blood level is just 5 to 15 micrograms per milliliter.

That's a tiny window.

It's a tiny window.

If it climbs just a little bit above 20, you see nausea, vomiting, and diarrhea.

And if it gets higher?

If it hits 30, you get severe ventricular fibrillation and seizures that are highly resistant to treatment.

It is a very dangerous drug to mismanage.

And the drug interactions are wild.

Caffeine is actually a methylanthine derivative too, so drinking coffee competes for the same metabolic pathways and worsens theophylline toxicity.

Right.

But the craziest interaction is with smoking, either tobacco or marijuana.

How does that work?

It is a fascinating pharmacokinetic quirk.

The chemicals in smoke actually induce or rev up the liver enzymes that metabolize theophylline.

It accelerates the clearance of the drug by up to 50%.

Wait, what does that mean for dosing?

It means a smoker actually requires a significantly higher dose of theophylline just to stay in that 5 to 15 therapeutic range.

So wait, if a patient on a massive dose of theophylline gets admitted to the hospital and suddenly quits smoking because they're in a smoke -free environment?

Their liver stops clearing the drug as fast, but they are still receiving that massive smoker's dose.

That's terrifying.

It is a recipe for a lethal overdose.

Their blood levels will skyrocket into the toxic range within days.

If a patient on theophylline quits smoking, you must alert the provider to drop the dose immediately.

Incredible.

Okay, finally, for bronchodilators, we have the anticholinergic drugs.

The mechanism here is blocking muscarinic receptors in the bronchi.

Acetylcholine naturally binds to these receptors to cause bronchoconstriction.

By blocking them, these drugs prevent the airways from tightening up.

We have short -acting muscarinic antagonists, or SAMAs like hypertropium, and long -acting LAMAs like teotropium.

Yes.

These are primarily approved for COPD.

And because they are inhaled directly into the lungs, you rarely see those classic systemic anticholinergic side effects, like urinary retention, blurred vision, or constipation.

Correct.

The systemic absorption is minimal.

However, local effects, primarily a very dry mouth, are incredibly common.

So we have all the puzzle pieces now.

We have the anti -inflammatories to stop the swelling, and the bronchodilators to stop the squeezing.

But how do we actually put it all together for the patient sitting in front of us?

Treating these diseases is kind of like driving a manual car.

You have to know when to shift gears up and down based on the terrain.

How do the clinical guidelines instruct nurses to manage asthma versus COPD?

Well, first we try to simplify it for them.

To increase compliance, we use combination drugs.

You can get an inhaler that combines a glucocorticoid and a laba -like advair or simbacort.

Well, that's smart.

Yeah.

This ensures the patient gets both mechanisms in one puff.

And crucially, it prevents an asthmatic from ever accidentally taking a laba by itself.

When it comes to managing asthma, the clinical guidelines use a stepwise approach.

And the gold standard for assessing how bad the asthma is, is measuring their FEV1, right?

Forced expiratory volume in one second.

Exactly.

Basically, how much air can you forcefully blow out of your lungs in one second?

Based on that FEV1 and how often they have symptoms, asthma is broken into intermittent or mild, moderate, and severe persistent.

Okay, so how do you step up the therapy?

Step one for intermittent asthma is just a short -acting sabah, PRN.

But if they are using it more than twice a week, you step up to step two, adding a low -dose inhaled glucocorticoid.

If that doesn't work, step three adds a labo.

You basically keep stepping up the doses until their breathing is controlled.

And conversely, if their asthma is perfectly controlled for several months, you try to carefully step down the therapy to minimize drug exposure.

But what if the stepwise approach fails and they crash?

What is the acute hospital protocol for a severe asthma exacerbation?

It's a rapid four -pronged attack.

First, immediate oxygen to relieve the hypoxemia.

Second, a systemic glucocorticoid to drastically cut the mass of inflammation.

Third, a nebulized high -dose sabah to force the airway muscles open.

And fourth, nebulized hypertropium to further block any muscarinic constriction.

Now, managing COPD operates on a totally different philosophy.

The guidelines classify stable COPD patients into groups, A through D, based on their daily symptoms and their risk of future exacerbations.

Because COPD is a progressive, destructive disease, the mainstays of therapy here are the long -acting bronchodilators, the labas and llamas.

Unlike asthma, inhaled glucocorticoids are not recommended as monotherapy early on.

They are really only added in for severe, high -risk groups to manage chronic inflammation.

And when a severe COPD exacerbation hits, it's managed similarly to asthma with sabahs, systemic glucocorticoids, and oxygen.

But there are two major differences.

First, you have to titrate the oxygen very carefully, usually keeping oxygen saturation between 88 and 92 percent so you don't suppress their respiratory drive.

Second, you aggressively use antibiotics.

Why antibiotics?

Because COPD exacerbations are frequently triggered by underlying bacterial respiratory infections which just thrive in that excessive mucus.

Summarizing the major nursing implications from all of this for you.

You must assess baseline FEV1.

You have to explicitly teach correct inhaler and spacer technique, otherwise the drug is just hitting the back of their throat.

You must vigilantly watch for oral thrush with inhaled glucocorticoids and reinforce mouth rinsing.

You have to monitor theophylline blood levels like a hawk, keeping them between 5 and 15, and watch for lifestyle changes like smoking cessation.

You must continually verify that ALEVA is never, ever being used as a solo maintenance therapy in an asthmatic patient.

It requires deep understanding and constant vigilance, which actually brings up a fascinating thought to leave you with.

Let's hear it.

As we move further into the era of precision medicine, we are seeing these incredibly specific biologic therapies that target exact inflammatory pathways.

Will there be a day in the near future where these highly precise genetic level monoclonals completely replace our broad stroke traditional glucocorticoids?

Wow, that would change everything.

It would.

Will the entire stepwise foundation of respiratory care we just learned be entirely rewritten?

It's amazing to consider.

Instead of just managing the fire after it starts, we might soon be able to genetically fireproof the airways altogether.

But until then, when you walk onto the floor, you aren't just memorizing drug names.

You are armed with the why behind every puff, pill, and nebulizer.

You are ready to safely manage these complex medications and protect those airways.

From the Last Minute Lecture team, thank you for joining us to conquer this material.

We'll see you on the next deep dive.